10.6084/m9.figshare.c.3623249_D3.v1 Eduardo Castañón Eduardo Castañón Christian Rolfo Christian Rolfo David Viñal David Viñal Inés López Inés López Juan Fusco Juan Fusco Marta Santisteban Marta Santisteban Patricia Martin Patricia Martin Leire Zubiri Leire Zubiri José Echeveste José Echeveste Ignacio Gil-Bazo Ignacio Gil-Bazo Additional file 4: of Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis Springer Nature 2015 Liver metastasis Non-small cell lung cancer (NSCLC) Epidermal growth factor receptor (EGFR) EGFR tyrosin-kinase inhibitors Prognosis 2015-08-07 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_Impact_of_epidermal_growth_factor_receptor_EGFR_activating_mutations_and_their_targeted_treatment_in_the_prognosis_of_stage_IV_non-small_cell_lung_cancer_NSCLC_patients_harboring_liver_metastasis/4400564 Table S4. Univariate Regression Model for predicting OS (overall survival) in our clinical series.